← Back
$LBRX All transactions

LB PHARMACEUTICALS INC

▲ BUY
10 / 10

Conviction

$ Value

$5.0M

Shares

332,566

Price

$15

Filed

Sep 16

Why this score? (10/10)
  • Open market buy (+3)
  • Trade value >= $1.0M (+2)
  • % of holdings >= 20% (+2)
  • 10%+ owner (+1)
  • Cluster: 4 insiders buying (+2)
  • Not a 10b5-1 plan (+1)

Insider

Name

Vida Ventures GP III, L.L.C.

Title

CIK

0001855502

Roles

10% Owner

Transaction Details

Transaction Date

2025-09-12

Code

P

Table

Non-Derivative

Ownership

Indirect

Equity Swap

No

Shares After

880,214

Footnotes

Each share of Series C Preferred Stock has no expiration date and converted automatically into Common Stock immediately prior to the Issuer's initial public offering at a conversion ratio based upon the initial price per share to the public in the Issuer's initial public offering. | These shares are held directly by Vida Ventures III, L.P. ("Vida III"). Vida Ventures GP III, L.L.C. ("Vida III GP") is the general partner of Vida III and may be deemed to have voting, investment, and dispositive power with respect to these securities. Arie Belldegrun, Helen Kim and Rajul Jain, are the members of the investment committee of Vida III GP (each, an "Investment Committee Member" and such committee, the "Investment Committee"). | (Continued from Footnote 2) The Investment Committee and each of the Investment Committee Members may be deemed to share voting, investment and dispositive power with respect to these securities. Vida III GP, the Investment Committee and each of the Investment Committee Members disclaims beneficial ownership of the securities held of record by Vida III, and this report shall not be deemed an admission that they are the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their pecuniary interest therein, if any. | These shares are held directly by Vida Ventures III-A, L.P. ("Vida III-A"). Vida III GP is the general partner of Vida III-A and may be deemed to have voting, investment, and dispositive power with respect to these securities. The Investment Committee and each of the Investment Committee Members may be deemed to share voting, investment and dispositive power with respect to these securities. Vida III GP, the Investment Committee and each of the Investment Committee Members disclaims beneficial ownership of the securities held of record by Vida III-A, and this report shall not be deemed an admission that they are the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their pecuniary interest therein, if any. | These shares are held directly by Vida Ventures Management Co., LLC ("Vida Management"). Each Investment Committee Member (as defined below) disclaims beneficial ownership of the securities held of record by Vida Management, and this report shall not be deemed an admission that they are the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their pecuniary interest therein, if any.

Filing Info

Accession No.

0001193125-25-204935

Form Type

4

Issuer CIK

0001691082

Vida Ventures GP III, L.L.C.'s History

Date Ticker Type Value
2025-09-12 LBRX C
2025-09-12 LBRX C
2025-09-12 LBRX $5.0M
2025-09-12 LBRX $12K
2025-09-12 LBRX C $0
2025-09-12 LBRX C $0

Other Insiders at LBRX (90d)

Insider Bought Sold Last
Deep Track Biotechnology Master Fund, Ltd. $10.0M 2026-02-06
Lenz Robert A. 2026-03-06